Search results
FDA adds Fasenra indication for severe asthma in children
Medical Xpress· 6 days agoThe U.S. Food and Drug Administration has approved an additional indication for AstraZeneca's ...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 5 hours agoAstraZeneca’s other drugs, Fasenra, Calquence and newer products, asthma drug Tezspire and lupus...
11 Best Low Price Pharma Stocks To Invest In
Insider Monkey via Yahoo Finance· 2 days agoIn this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want...
AstraZeneca (AZN) to Release Earnings on Thursday
ETF DAILY NEWS· 17 hours agoAstraZeneca (NASDAQ:AZN – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, April 25th. Analysts expect the company to announce earnings of $0.97 per ...
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Zacks via Yahoo Finance· 1 day agoBeyond analysts' top -and-bottom-line estimates for Astrazeneca (AZN), evaluate projections for some...
Cetera Trust Company N.A Purchases Shares of 3,700 AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 1 day agoCetera Trust Company N.A purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with ...
Zacks Research Weighs in on AstraZeneca PLC’s Q2 2025 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 5 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Equities research analysts at Zacks Research cut their Q2 2025 EPS estimates for shares of AstraZeneca in a research note issued to investors on ...
Greenleaf Trust Sells 1,500 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoGreenleaf Trust trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities ...
